BIRAC
BIRAC’s AcE Fund aims to foster R&D and innovation by encouraging VC investment for biotech Startups & SMEs through its AIFs daughter funds (AcE Fund Partners)

For more details click to view guidelines and FAQ.

Impact

150

(INR CR)

Fund Corpus BIRAC/DBT

10

Number of Daughter funds

300

(INR CR)

Investment commitment for Biotech startups

65

Number of Startups supported

733.53

(INR CR)

Investment done in Biotech startups

(Last updated on: Oct 2022)

seed fund
Fund of Funds
Biotechnology Innovation Fund - AcE (Accelerating Entrepreneurs)

“Fund of Funds - AcE” fosters R&D and innovation in Biotechnology domains by plugging the funding gap encountered by the biotech startups during their ‘product development cycle’ and ‘growth phase’. AcE Fund invests and partners with SEBI- registered Category I and II AIFs, which are professionally managed and keen to invest in biotech sector. The Daughter Funds commit to invest in the Biotech startups & SMEs 2x of BIRAC’s committed investment in the Funds.

Biotech sub–sectors include Healthcare, Life Sciences, Pharma, Biopharma, Med-tech, Diagnostics, Industrial-Biotech, Agri-tech, Bio-IT/Services and allied areas.

BIRAC AcE FUND PARTNERS

Startups can avail BIRAC AcE Fund through any of the following AcE Fund Partners

Indian Angel Network
Gujarat Venture Finance Limited
Stake Boat Capital
Kitven Fund
Bharat Innovation Fund
Somerset Healthcare Investment Advisors Private Limited
Ankur Capital
Endiya Fund Advisors Pvt. Ltd
Rajasthan Venture Capital Fund
Nabvenutre Fund